Stay updated on Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Sign up to get notified when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.

Latest updates to the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page
- ChecktodayChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the record. The visible content and study details appear unchanged.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe MedlinePlus related topics block with links to 'Multiple Myeloma' and 'MedlinePlus Genetics' has been removed from the page, reducing quick-access background links for readers.SummaryDifference0.1%

- Check22 days agoChange DetectedAn updated citation entry is reflected for a referenced paper related to multiple myeloma, with the previously shown erratum/correction text removed. The page also shows an updated site/application revision number.SummaryDifference0.1%

- Check29 days agoChange DetectedAdded 'Multiple myeloma' and 'MedlinePlus Genetics' related topics, and updated the revision from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check43 days agoChange DetectedAdded the Dimopoulos et al. 2007 NEJM article to Publications. Removed the Erratum for that article (2009) from the References.SummaryDifference0.0%

- Check51 days agoChange DetectedRemoved the Multiple myeloma topic and related resources, including MedlinePlus Genetics, from the page's topics/related resources.SummaryDifference0.1%

Stay in the know with updates to Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.